Double Medical Technology Inc. (SHE:002901)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Trauma Product	998.52M	842.20M	572.37M	542.45M	1.13B
Trauma Product Growth	18.56%	47.14%	5.52%	-51.89%	14.97%
Spine Product	493.13M	394.33M	283.67M	472.10M	565.38M
Spine Product Growth	25.06%	39.01%	-39.91%	-16.50%	53.14%
Minimally Invasive Surgery Products	408.90M	368.78M	286.64M	191.60M	149.63M
Minimally Invasive Surgery Products Growth	10.88%	28.65%	49.60%	28.05%	34.20%
Joint Products	252.18M	202.54M	156.32M	58.61M	21.45M
Joint Products Growth	24.51%	29.57%	166.70%	173.25%	-
Neurosurgical Products	114.35M	82.44M	81.48M	46.99M	43.82M
Neurosurgical Products Growth	38.70%	1.18%	73.41%	7.23%	14.93%
Dental Products	71.13M	65.84M	52.26M	24.76M	-
Dental Products Growth	8.04%	25.99%	111.08%	-	-
Other Products	262.65M	179.43M	67.14M	74.05M	60.97M
Other Products Growth	46.38%	167.25%	-9.33%	21.45%	10.16%
Surgical Instrument	-	-	33.23M	23.53M	20.45M
Surgical Instrument Growth	-	-	41.21%	15.06%	-28.36%
Total	2.60B	2.14B	1.53B	1.43B	1.99B
Total Growth	21.79%	39.29%	6.90%	-27.91%	25.63%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	2.29B	1.92B	1.32B	1.36B	1.91B
China Growth	19.30%	45.71%	-2.84%	-29.21%	24.09%
Abroad	311.98M	216.94M	216.40M	78.94M	79.94M
Abroad Growth	43.81%	0.25%	174.13%	-1.26%	81.08%
Total	2.60B	2.14B	1.53B	1.43B	1.99B
Total Growth	21.79%	39.29%	6.90%	-28.09%	25.68%

Source: S&P Global Market Intelligence.